HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

QYUNS-B

16.240

-0.180-1.10%

Volume:123.80K

Turnover:2.03M

Market Cap:3.62B

PE:9.86

High:16.800

Open:16.170

Low:16.000

Close:16.420

52wk High:36.500

52wk Low:13.210

Shares:223.00M

HK Float Shares:223.00M

Volume Ratio:3.38

T/O Rate:0.06%

Dividend:- -

Dividend Rate:- -

EPS(LYR):1.648

ROE:101.58%

ROA:22.80%

PB:3.60

PE(LYR):9.86

PS:3.02

Loading ...

Overview Company News Filings

QYUNS-B (02509) Repurchases 174,400 Shares for Approximately HK$2.81 Million on June 1

Qyuns Therapeutics Buys Back 174,400 H-Shares, Expands Treasury Stock to 2.88 Million Shares

Bulletin Express

Qyuns Therapeutics Updates Articles of Association: Clarifies Share Structure, Governance Framework and Dividend Policy

Bulletin Express

Qyuns Therapeutics dissolves supervisory committee as supervisors resign

Qyuns Therapeutics repurchases 70,000 H-shares; treasury stock rises to 2.71 million units

Bulletin Express

BRIEF-Qyuns Therapeutics Co Receives Milestone Payment From Roche

QYUNS-B Receives Milestone Payment from Roche Following First Patient Dosing in Phase I Trial for QX031N

Qyuns Therapeutics receives Roche milestone payment after first QX031N Phase I patient dosed

Qyuns Therapeutics Co - Receives Milestone Payment From Roche for First Participant Dosed in Phase I QX031n Trial

THOMSON REUTERS

QYUNS-B (02509) Allocates HK$2.19 Million for Share Buyback on May 27

Qyuns Therapeutics files HKEX next-day return disclosing share repurchase at HKD 16.31 each

Qyuns Therapeutics secures NMPA approval for biosimilar QX001S (Ustekinumab) in Crohn’s disease, in partnership with Zhongmei Huadong

Bulletin Express

QYUNS-B (02509) Gains Approval for Marketing Authorization and Supplemental Application of QX001S (Ustekinumab Injection) for Crohn's Disease

Qyuns Therapeutics - Zhongmei Huadong Receives Approvals for QX001s (Ustekinumab Injection) for Crohn's Disease

THOMSON REUTERS

QYUNS-B (02509) Rises Over 3% Following Windward Bio's Completion of $165 Million Crossover Financing to Advance WIN027 Clinical Study

Qyuns Therapeutics Rolls Out 10-Year Share Incentive Plan; Mandate Capped at 10% of Issued H Shares

Bulletin Express

Qyuns Therapeutics to Vote on Profit Distribution, KPMG Re-appointment and New 2026 Share Incentive Scheme at 29 May 2026 AGM

Bulletin Express

Qyuns Therapeutics Tables Key AGM Proposals: No 2025 Dividend, HK$111.70 Million Proceeds Reallocated, Launches 10-Year Share Incentive Scheme

Bulletin Express

Qyuns Therapeutics announces annual general meeting

BRIEF-Qyuns Therapeutics To Subscribe PDB Wealth Product With RMB100 Million Principal

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnest.com/stock/02509/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"02509","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02509\",,,,,undefined,":{"symbol":"02509","market":"HK","secType":"STK","nameCN":"QYUNS-B","latestPrice":16.24,"timestamp":1789108364663,"preClose":16.42,"halted":0,"volume":123800,"delay":0,"changeRate":-0.010962241169305923,"floatShares":223000000,"shares":223000000,"eps":1.647782700752823,"marketStatus":"Trading","change":-0.18,"latestTime":"09-11 15:23:55","open":16.17,"high":16.8,"low":16,"amount":2031922,"amplitude":0.048721,"askPrice":16.46,"askSize":4400,"bidPrice":16.11,"bidSize":400,"shortable":3,"etf":0,"ttmEps":2.8373415738707655,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1789114200000},"marketStatusCode":2,"adr":0,"listingDate":1710864000000,"exchange":"SEHK","adjPreClose":16.42,"openAndCloseTimeList":[[1789090200000,1789099200000],[1789102800000,1789113600000]],"volumeRatio":3.379358,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02509\",,,,,undefined,":{"symbol":"02509","floatShares":223000000,"roa":"22.80%","roe":"101.58%","lyrEps":1.647783,"volumeRatio":3.379358,"shares":223000000,"dividePrice":0,"high":16.8,"amplitude":0.048721,"preClose":16.42,"low":16,"week52Low":13.21,"pbRate":"3.60","psRate":"3.02","week52High":36.5,"institutionHeld":0,"latestPrice":16.24,"committee":-0.833333,"eps":1.647782700752823,"divideRate":0,"volume":123800,"delay":0,"ttmEps":2.8373415738707655,"open":16.17,"prevYearClose":18.78,"prevWeekClose":16.44,"prevMonthClose":16.66,"prevQuarterClose":14.18,"fiveDayClose":16.44,"twentyDayClose":17.64,"sixtyDayClose":14.29},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02509\",params:#limit:5,,,undefined,":[{"date":"2026-08-19","symbol":"02509","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787103000000,"name":null,"time":"","dateTimestamp":1787068800000,"actualEps":null},{"date":"2026-03-27","symbol":"02509","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774575000000,"name":null,"time":"","dateTimestamp":1774540800000,"actualEps":null},{"date":"2025-03-28","symbol":"02509","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1743125400000,"name":null,"time":"Post-Mkt","dateTimestamp":1743091200000,"actualEps":null},{"date":"2024-08-15","symbol":"02509","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1723685400000,"name":null,"time":"","dateTimestamp":1723651200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02509\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02509\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1769011200000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02509\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02509","date":"2026-09-10","current":5.723329,"percent":0.823723,"low":-38.274716,"twenty":-19.79914,"median":-9.013863,"eighty":-3.405638,"high":13.150203,"avg":-8.772059,"sd":11.621926,"marketCap":3667771524},"quantilePoints":[{"date":"2024-03-22","current":-9.005941,"twenty":-9.920087,"median":-9.005941,"eighty":-8.797979,"marketCap":4652400020},{"date":"2024-03-28","current":-9.367246,"twenty":-9.484937,"median":-9.005941,"eighty":-8.416995,"marketCap":4821843660},{"date":"2024-04-05","current":-8.872714,"twenty":-9.396669,"median":-8.977885,"eighty":-8.598751,"marketCap":4565907160},{"date":"2024-04-12","current":-9.165919,"twenty":-9.386227,"median":-9.126184,"eighty":-8.830039,"marketCap":4719469060},{"date":"2024-04-19","current":-9.074252,"twenty":-9.304842,"median":-9.125412,"eighty":-8.934406,"marketCap":4668281760},{"date":"2024-04-26","current":-9.882424,"twenty":-9.513374,"median":-9.232059,"eighty":-8.994719,"marketCap":5077780160},{"date":"2024-05-03","current":-10.208268,"twenty":-9.517937,"median":-9.234052,"eighty":-9.046928,"marketCap":5241579520},{"date":"2024-05-10","current":-10.950727,"twenty":-10.058378,"median":-9.328243,"eighty":-9.081967,"marketCap":6018140360},{"date":"2024-05-17","current":-11.513141,"twenty":-10.522167,"median":-9.424295,"eighty":-9.09098,"marketCap":6317937020},{"date":"2024-05-24","current":-11.397533,"twenty":-11.287555,"median":-9.513128,"eighty":-9.098359,"marketCap":6240211960},{"date":"2024-05-31","current":-10.960491,"twenty":-11.380385,"median":-9.702863,"eighty":-9.110289,"marketCap":6007036780},{"date":"2024-06-07","current":-9.736726,"twenty":-11.329803,"median":-9.882424,"eighty":-9.125257,"marketCap":5329718400},{"date":"2024-06-14","current":-9.786262,"twenty":-11.239813,"median":-9.736726,"eighty":-9.134131,"marketCap":5351925560},{"date":"2024-06-21","current":-11.51586,"twenty":-11.394726,"median":-9.834343,"eighty":-9.179147,"marketCap":6284626280},{"date":"2024-06-28","current":-7.449742,"twenty":-11.394726,"median":-9.882424,"eighty":-9.134131,"marketCap":4063910280},{"date":"2024-07-05","current":-8.013266,"twenty":-11.3835,"median":-9.736726,"eighty":-9.096784,"marketCap":4370369088},{"date":"2024-07-12","current":-8.782148,"twenty":-11.375713,"median":-9.612459,"eighty":-8.973485,"marketCap":4796746560},{"date":"2024-07-19","current":-8.033889,"twenty":-11.260937,"median":-9.536435,"eighty":-8.759388,"marketCap":4388134816},{"date":"2024-07-26","current":-8.627957,"twenty":-11.24224,"median":-9.513744,"eighty":-8.627957,"marketCap":4730125080},{"date":"2024-08-02","current":-9.119354,"twenty":-11.155317,"median":-9.51436,"eighty":-8.659337,"marketCap":4996611000},{"date":"2024-08-09","current":-9.602516,"twenty":-11.096166,"median":-9.502501,"eighty":-8.759388,"marketCap":5296407660},{"date":"2024-08-16","current":-9.659156,"twenty":-11.082764,"median":-9.523303,"eighty":-8.782148,"marketCap":5329718400},{"date":"2024-08-23","current":-11.457751,"twenty":-11.24224,"median":-9.560506,"eighty":-8.785621,"marketCap":5274200500},{"date":"2024-08-30","current":-11.261539,"twenty":-11.260937,"median":-9.602516,"eighty":-8.853804,"marketCap":5218682600},{"date":"2024-09-06","current":-12.381731,"twenty":-11.301814,"median":-9.616314,"eighty":-8.872714,"marketCap":5740550860},{"date":"2024-09-13","current":-12.966504,"twenty":-11.41285,"median":-9.666597,"eighty":-8.919616,"marketCap":5995933200},{"date":"2024-09-20","current":-13.175636,"twenty":-11.495182,"median":-9.727036,"eighty":-8.943786,"marketCap":6129176160},{"date":"2024-09-27","current":-11.412309,"twenty":-11.503472,"median":-9.834343,"eighty":-8.968754,"marketCap":5340821980},{"date":"2024-10-04","current":-10.630177,"twenty":-11.500266,"median":-9.955419,"eighty":-8.992959,"marketCap":4952196680},{"date":"2024-10-10","current":-9.640046,"twenty":-11.496891,"median":-9.984689,"eighty":-9.012278,"marketCap":4463639160},{"date":"2024-10-18","current":-7.823087,"twenty":-11.483911,"median":-9.882424,"eighty":-8.891475,"marketCap":3602001352},{"date":"2024-10-25","current":-6.637022,"twenty":-11.464072,"median":-9.731881,"eighty":-8.768492,"marketCap":3055705216},{"date":"2024-11-01","current":-6.266219,"twenty":-11.439791,"median":-9.666597,"eighty":-8.552796,"marketCap":2886930800},{"date":"2024-11-08","current":-6.11978,"twenty":-11.412634,"median":-9.628889,"eighty":-8.354641,"marketCap":2798102160},{"date":"2024-11-15","current":-4.903744,"twenty":-11.406399,"median":-9.610023,"eighty":-8.146037,"marketCap":2225157432},{"date":"2024-11-22","current":-4.446271,"twenty":-11.39192,"median":-9.574881,"eighty":-7.917147,"marketCap":2016410128},{"date":"2024-11-29","current":-5.262129,"twenty":-11.380385,"median":-9.536435,"eighty":-7.700796,"marketCap":2385048984},{"date":"2024-12-06","current":-5.795133,"twenty":-11.346153,"median":-9.513744,"eighty":-7.24659,"marketCap":2620444880},{"date":"2024-12-13","current":-4.23234,"twenty":-11.292835,"median":-9.462151,"eighty":-6.614509,"marketCap":1912036476},{"date":"2024-12-20","current":-3.65763,"twenty":-11.272236,"median":-9.353096,"eighty":-6.423955,"marketCap":1643329840},{"date":"2024-12-27","current":-3.704989,"twenty":-11.261539,"median":-9.289241,"eighty":-6.377951,"marketCap":1663316284},{"date":"2025-01-03","current":-3.459219,"twenty":-11.261057,"median":-9.234052,"eighty":-6.353973,"marketCap":1554501200},{"date":"2025-01-10","current":-3.422771,"twenty":-11.250301,"median":-9.146052,"eighty":-6.232964,"marketCap":1532294040},{"date":"2025-01-17","current":-3.325837,"twenty":-11.24332,"median":-9.119354,"eighty":-5.607796,"marketCap":1490100436},{"date":"2025-01-24","current":-3.940539,"twenty":-11.188065,"median":-9.092192,"eighty":-5.378133,"marketCap":1776572800},{"date":"2025-01-28","current":-4.706176,"twenty":-11.17068,"median":-9.087355,"eighty":-5.266211,"marketCap":2131887360},{"date":"2025-02-07","current":-3.301677,"twenty":-11.154739,"median":-9.066381,"eighty":-4.958001,"marketCap":1487879720},{"date":"2025-02-14","current":-3.418254,"twenty":-11.143754,"median":-8.989713,"eighty":-4.539173,"marketCap":1536735472},{"date":"2025-02-21","current":-3.43891,"twenty":-11.106485,"median":-8.919616,"eighty":-4.354459,"marketCap":1554501200},{"date":"2025-02-28","current":-3.351703,"twenty":-11.093486,"median":-8.819713,"eighty":-4.122814,"marketCap":1510086880},{"date":"2025-03-07","current":-3.387392,"twenty":-11.071174,"median":-8.759388,"eighty":-3.975573,"marketCap":1532294040},{"date":"2025-03-14","current":-5.398225,"twenty":-11.023325,"median":-8.622598,"eighty":-3.975573,"marketCap":2442787600},{"date":"2025-03-21","current":-4.408646,"twenty":-11.005989,"median":-8.475358,"eighty":-3.996365,"marketCap":1994202968},{"date":"2025-03-28","current":-4.427424,"twenty":-10.958538,"median":-8.354936,"eighty":-4.069456,"marketCap":1998644400},{"date":"2025-04-03","current":-5.532239,"twenty":-10.950727,"median":-8.251895,"eighty":-4.071454,"marketCap":1987540820},{"date":"2025-04-11","current":-5.176788,"twenty":-10.949179,"median":-8.134698,"eighty":-4.113712,"marketCap":1843194280},{"date":"2025-04-17","current":-5.605956,"twenty":-10.931954,"median":-8.013266,"eighty":-4.15012,"marketCap":1998644400},{"date":"2025-04-25","current":-6.813611,"twenty":-10.860673,"median":-7.855635,"eighty":-4.203093,"marketCap":2433904736},{"date":"2025-05-02","current":-6.97286,"twenty":-10.741685,"median":-7.823087,"eighty":-4.240312,"marketCap":2496084784},{"date":"2025-05-09","current":-6.850326,"twenty":-10.62989,"median":-7.688151,"eighty":-4.256936,"marketCap":2469436192},{"date":"2025-05-16","current":-6.660384,"twenty":-10.625613,"median":-7.362552,"eighty":-4.28571,"marketCap":2420580440},{"date":"2025-05-23","current":-6.920763,"twenty":-10.596701,"median":-7.188701,"eighty":-4.327055,"marketCap":2522733376},{"date":"2025-05-30","current":-6.975387,"twenty":-10.531077,"median":-7.035719,"eighty":-4.335168,"marketCap":2553823400},{"date":"2025-06-06","current":-8.954176,"twenty":-10.530643,"median":-7.056435,"eighty":-4.354459,"marketCap":3286659680},{"date":"2025-06-13","current":-10.1118,"twenty":-10.525842,"median":-7.245424,"eighty":-4.362058,"marketCap":3713037152},{"date":"2025-06-20","current":-9.295434,"twenty":-10.49786,"median":-7.449742,"eighty":-4.377592,"marketCap":3406578344},{"date":"2025-06-27","current":-9.088195,"twenty":-10.44408,"median":-7.654473,"eighty":-4.399074,"marketCap":3339956864},{"date":"2025-07-04","current":-9.256954,"twenty":-10.441448,"median":-7.771425,"eighty":-4.408646,"marketCap":3402136912},{"date":"2025-07-11","current":-9.278386,"twenty":-10.438605,"median":-7.855635,"eighty":-4.408983,"marketCap":3406578344},{"date":"2025-07-18","current":-10.375245,"twenty":-10.375245,"median":-8.023578,"eighty":-4.415927,"marketCap":3806307224},{"date":"2025-07-25","current":-11.242346,"twenty":-10.444738,"median":-8.163045,"eighty":-4.427424,"marketCap":4139414624},{"date":"2025-08-01","current":-12.956889,"twenty":-10.531115,"median":-8.317696,"eighty":-4.446271,"marketCap":4741228660},{"date":"2025-08-08","current":-12.531071,"twenty":-10.816023,"median":-8.356409,"eighty":-4.497422,"marketCap":4596882120},{"date":"2025-08-15","current":-13.616918,"twenty":-10.950727,"median":-8.486422,"eighty":-4.706176,"marketCap":4987728136},{"date":"2025-08-22","current":-28.922954,"twenty":-11.024815,"median":-8.611071,"eighty":-4.860396,"marketCap":6035906088},{"date":"2025-08-29","current":-26.076607,"twenty":-11.152426,"median":-8.643647,"eighty":-4.89511,"marketCap":5467884128},{"date":"2025-09-05","current":-27.424941,"twenty":-11.24224,"median":-8.759388,"eighty":-4.895913,"marketCap":5744911480},{"date":"2025-09-12","current":-33.976118,"twenty":-11.261539,"median":-8.783884,"eighty":-4.903744,"marketCap":7130048240},{"date":"2025-09-19","current":-32.137812,"twenty":-11.3835,"median":-8.872714,"eighty":-4.920955,"marketCap":6739485088},{"date":"2025-09-26","current":-31.917438,"twenty":-11.446602,"median":-8.942813,"eighty":-4.93749,"marketCap":6675905040},{"date":"2025-10-03","current":-36.693474,"twenty":-11.494681,"median":-8.957754,"eighty":-4.939756,"marketCap":7693185808},{"date":"2025-10-10","current":-31.866218,"twenty":-11.50418,"median":-8.989713,"eighty":-4.971797,"marketCap":6671363608},{"date":"2025-10-17","current":-31.02267,"twenty":-11.536491,"median":-9.052042,"eighty":-5.060821,"marketCap":6489706328},{"date":"2025-10-24","current":-25.824743,"twenty":-11.67702,"median":-9.080681,"eighty":-5.119056,"marketCap":5404304080},{"date":"2025-10-31","current":-23.597698,"twenty":-11.854109,"median":-9.087898,"eighty":-5.129572,"marketCap":4945619448},{"date":"2025-11-07","current":-20.869587,"twenty":-12.197299,"median":-9.096784,"eighty":-5.138538,"marketCap":4371128300},{"date":"2025-11-14","current":-22.685433,"twenty":-12.458841,"median":-9.113568,"eighty":-5.155799,"marketCap":4764920384},{"date":"2025-11-21","current":-21.57415,"twenty":-12.521958,"median":-9.126184,"eighty":-5.17154,"marketCap":4529392000},{"date":"2025-11-28","current":-24.204574,"twenty":-12.94929,"median":-9.16505,"eighty":-5.177501,"marketCap":5100095392},{"date":"2025-12-05","current":-22.466634,"twenty":-13.164946,"median":-9.191702,"eighty":-5.178705,"marketCap":4742036512},{"date":"2025-12-12","current":-22.1097,"twenty":-13.511538,"median":-9.209948,"eighty":-5.212195,"marketCap":4675330264},{"date":"2025-12-19","current":-20.041803,"twenty":-17.63398,"median":-9.232059,"eighty":-5.270292,"marketCap":4248039442},{"date":"2025-12-24","current":-19.36285,"twenty":-19.558586,"median":-9.239461,"eighty":-5.282537,"marketCap":4116913158},{"date":"2026-01-02","current":-20.737965,"twenty":-19.704926,"median":-9.253177,"eighty":-5.315175,"marketCap":4426642484},{"date":"2026-01-09","current":-23.204245,"twenty":-20.357213,"median":-9.278386,"eighty":-5.378549,"marketCap":4965417516},{"date":"2026-01-16","current":-24.098803,"twenty":-20.760618,"median":-9.31719,"eighty":-5.397051,"marketCap":5173599760},{"date":"2026-01-23","current":-22.922252,"twenty":-21.536475,"median":-9.368149,"eighty":-5.401271,"marketCap":4916293200},{"date":"2026-01-30","current":-21.794057,"twenty":-21.687913,"median":-9.424295,"eighty":-5.425026,"marketCap":4695690300},{"date":"2026-02-06","current":-20.334967,"twenty":-21.659361,"median":-9.513128,"eighty":-5.511946,"marketCap":4392431440},{"date":"2026-02-13","current":-21.335749,"twenty":-21.659361,"median":-9.528371,"eighty":-5.55032,"marketCap":4635075264},{"date":"2026-02-20","current":-20.973148,"twenty":-21.649543,"median":-9.534937,"eighty":-5.562312,"marketCap":4549739576},{"date":"2026-02-27","current":-17.376769,"twenty":-21.609505,"median":-9.566812,"eighty":-5.593401,"marketCap":3810912172},{"date":"2026-03-06","current":-17.920587,"twenty":-21.564731,"median":-9.594832,"eighty":-5.599011,"marketCap":3898493536},{"date":"2026-03-13","current":-18.300829,"twenty":-21.488875,"median":-9.614895,"eighty":-5.602974,"marketCap":3999548956},{"date":"2026-03-20","current":-18.380704,"twenty":-21.336069,"median":-9.649601,"eighty":-5.606602,"marketCap":4001794632},{"date":"2026-03-27","current":-20.040776,"twenty":-21.318389,"median":-9.681606,"eighty":-5.612646,"marketCap":4352120088},{"date":"2026-04-02","current":12.478766,"twenty":-21.24895,"median":-9.659156,"eighty":-5.598207,"marketCap":4464403888},{"date":"2026-04-10","current":12.781914,"twenty":-21.241413,"median":-9.628889,"eighty":-5.5458,"marketCap":4608127152},{"date":"2026-04-17","current":12.751644,"twenty":-21.234144,"median":-9.610023,"eighty":-5.395876,"marketCap":4599144448},{"date":"2026-04-24","current":11.21309,"twenty":-21.216401,"median":-9.58505,"eighty":-5.228839,"marketCap":4044462476},{"date":"2026-04-30","current":10.7021,"twenty":-21.203518,"median":-9.560506,"eighty":-5.17154,"marketCap":3862562720},{"date":"2026-05-08","current":10.358859,"twenty":-21.109524,"median":-9.533439,"eighty":-5.114765,"marketCap":3750278920},{"date":"2026-05-15","current":10.61627,"twenty":-20.963352,"median":-9.513744,"eighty":-4.927569,"marketCap":3853580016},{"date":"2026-05-22","current":9.629856,"twenty":-20.934581,"median":-9.462151,"eighty":-4.874282,"marketCap":3487534828},{"date":"2026-05-29","current":10.418336,"twenty":-20.904691,"median":-9.37169,"eighty":-4.456501,"marketCap":3786209736},{"date":"2026-06-05","current":9.397468,"twenty":-20.865916,"median":-9.353096,"eighty":-4.408713,"marketCap":3420164548},{"date":"2026-06-12","current":9.885443,"twenty":-20.842881,"median":-9.289241,"eighty":-4.354459,"marketCap":3595327276},{"date":"2026-06-18","current":8.798669,"twenty":-20.809475,"median":-9.260665,"eighty":-4.275598,"marketCap":3206825328},{"date":"2026-06-26","current":8.4741,"twenty":-20.737965,"median":-9.247135,"eighty":-4.113712,"marketCap":3074330444},{"date":"2026-07-03","current":9.525463,"twenty":-20.637607,"median":-9.233055,"eighty":-3.977556,"marketCap":3458341040},{"date":"2026-07-10","current":9.469045,"twenty":-20.557354,"median":-9.218198,"eighty":-3.819713,"marketCap":3433638604},{"date":"2026-07-17","current":9.867437,"twenty":-20.504561,"median":-9.194332,"eighty":-3.699682,"marketCap":3590835924},{"date":"2026-07-24","current":9.994782,"twenty":-20.472909,"median":-9.165919,"eighty":-3.658551,"marketCap":3637995120},{"date":"2026-07-31","current":9.98398,"twenty":-20.387953,"median":-9.159435,"eighty":-3.646486,"marketCap":3640966860},{"date":"2026-08-07","current":10.600412,"twenty":-20.327675,"median":-9.121996,"eighty":-3.503724,"marketCap":3873273948},{"date":"2026-08-14","current":10.770175,"twenty":-20.154207,"median":-9.100722,"eighty":-3.481151,"marketCap":3940285608},{"date":"2026-08-21","current":5.952896,"twenty":-20.041187,"median":-9.088801,"eighty":-3.461369,"marketCap":3790626234},{"date":"2026-08-28","current":5.962068,"twenty":-20.033889,"median":-9.08711,"eighty":-3.438988,"marketCap":3797327400},{"date":"2026-09-04","current":5.763357,"twenty":-19.947731,"median":-9.059211,"eighty":-3.423277,"marketCap":3672238968},{"date":"2026-09-10","current":5.74809,"twenty":-19.79914,"median":-9.013863,"eighty":-3.405638,"marketCap":3667771524}],"updateTime":1789109288643},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02509\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1153733409","title":"QYUNS-B (02509) Repurchases 174,400 Shares for Approximately HK$2.81 Million on June 1","url":"https://stock-news.laohu8.com/highlight/detail?id=1153733409","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1153733409?lang=en_us&edition=fundamental","pubTime":"2026-06-01 21:44","pubTimestamp":1780321475,"startTime":"0","endTime":"0","summary":"QYUNS-B (02509) has disclosed that on June 1, 2026, the company expended approximately HK$2.81 million to repurchase 174,400 shares.","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100751279","title":"Qyuns Therapeutics Buys Back 174,400 H-Shares, Expands Treasury Stock to 2.88 Million Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1100751279","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100751279?lang=en_us&edition=fundamental","pubTime":"2026-06-01 21:44","pubTimestamp":1780321441,"startTime":"0","endTime":"0","summary":"Qyuns Therapeutics Co., Ltd. (QYUNS-B) disclosed a share-repurchase transaction conducted on 1 June 2026 under its Hong Kong Stock Exchange mandate approved on 29 May 2026. • Transaction details...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118253443","title":"Qyuns Therapeutics Updates Articles of Association: Clarifies Share Structure, Governance Framework and Dividend Policy","url":"https://stock-news.laohu8.com/highlight/detail?id=1118253443","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1118253443?lang=en_us&edition=fundamental","pubTime":"2026-05-29 19:04","pubTimestamp":1780052675,"startTime":"0","endTime":"0","summary":"Qyuns Therapeutics Co., Ltd. released its revised Articles of Association dated May 2026, detailing the company’s capital composition, shareholder rights and corporate governance mechanisms. Key...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639214746","title":"Qyuns Therapeutics dissolves supervisory committee as supervisors resign","url":"https://stock-news.laohu8.com/highlight/detail?id=2639214746","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639214746?lang=en_us&edition=fundamental","pubTime":"2026-05-29 18:59","pubTimestamp":1780052367,"startTime":"0","endTime":"0","summary":"Qyuns Therapeutics dissolved its supervisory committee effective May 29, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Qyuns Therapeutics Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange  , on May 29, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260529:nNDL1pHP2v:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02509","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152568699","title":"Qyuns Therapeutics repurchases 70,000 H-shares; treasury stock rises to 2.71 million units","url":"https://stock-news.laohu8.com/highlight/detail?id=1152568699","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152568699?lang=en_us&edition=fundamental","pubTime":"2026-05-28 20:22","pubTimestamp":1779970965,"startTime":"0","endTime":"0","summary":"Qyuns Therapeutics Co., Ltd. disclosed that on 28 May 2026 it bought back 70,000 H-shares on the Hong Kong Stock Exchange at prices ranging from HKD 16.21 to HKD 16.60 per share, for a total...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638681650","title":"BRIEF-Qyuns Therapeutics Co Receives Milestone Payment From Roche","url":"https://stock-news.laohu8.com/highlight/detail?id=2638681650","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638681650?lang=en_us&edition=fundamental","pubTime":"2026-05-27 23:05","pubTimestamp":1779894342,"startTime":"0","endTime":"0","summary":"BRIEF-Qyuns Therapeutics Co Receives Milestone Payment From RocheMay 27 (Reuters) - Qyuns Therapeutics Co Ltd 2509.HK:RECEIVES MILESTONE PAYMENT FROM ROCHE FOR FIRST PARTICIPANT DOSED IN PHASE I QX031N TRIALFurther company coverage: 2509.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260527:nFWN4240Q5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162349960","title":"QYUNS-B Receives Milestone Payment from Roche Following First Patient Dosing in Phase I Trial for QX031N","url":"https://stock-news.laohu8.com/highlight/detail?id=1162349960","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162349960?lang=en_us&edition=fundamental","pubTime":"2026-05-27 21:02","pubTimestamp":1779886961,"startTime":"0","endTime":"0","summary":"QYUNS-B (02509) announced that it received a milestone payment from its partner F. Hoffmann-La Roche Ltd (referred to as \"Roche\") on May 27, 2026. The payment was triggered upon the completion of the...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02509","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638168821","title":"Qyuns Therapeutics receives Roche milestone payment after first QX031N Phase I patient dosed","url":"https://stock-news.laohu8.com/highlight/detail?id=2638168821","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638168821?lang=en_us&edition=fundamental","pubTime":"2026-05-27 20:55","pubTimestamp":1779886554,"startTime":"0","endTime":"0","summary":"Qyuns Therapeutics received a milestone payment from Roche on May 27, 2026, tied to first dosing in a Phase I trial of QX031N .The first participant was dosed on March 27, 2026, in a first-in-human study in New Zealand across healthy volunteers, COPD, asthma.Roche holds global exclusive rights to develop, manufacture, commercialize QX031N under an Oct. 28, 2025 collaboration and license agreement.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Qyuns Therapeutics Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange  , on May 27, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260527:nNDL3Rv0Nl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02509","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638688297","title":"Qyuns Therapeutics Co - Receives Milestone Payment From Roche for First Participant Dosed in Phase I QX031n Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2638688297","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638688297?lang=en_us&edition=fundamental","pubTime":"2026-05-27 20:55","pubTimestamp":1779886545,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260527:nFWN4240Q5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02509","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139887506","title":"QYUNS-B (02509) Allocates HK$2.19 Million for Share Buyback on May 27","url":"https://stock-news.laohu8.com/highlight/detail?id=1139887506","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139887506?lang=en_us&edition=fundamental","pubTime":"2026-05-27 20:26","pubTimestamp":1779884809,"startTime":"0","endTime":"0","summary":"QYUNS-B (02509) announced that on May 27, 2026, the company executed a share repurchase, spending approximately HK$2.19 million to buy back 134,200 shares. The repurchase price ranged from HK$15.99 to HK$16.52 per share.","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02509","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638500559","title":"Qyuns Therapeutics files HKEX next-day return disclosing share repurchase at HKD 16.31 each","url":"https://stock-news.laohu8.com/highlight/detail?id=2638500559","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638500559?lang=en_us&edition=fundamental","pubTime":"2026-05-27 20:13","pubTimestamp":1779884004,"startTime":"0","endTime":"0","summary":"Qyuns Therapeutics repurchased 134,200 H shares on May 27 at a volume-weighted average HKD 16.31 each.Buyback prices ranged from HKD 15.99 to HKD 16.52; aggregate consideration totaled HKD 2.19 million.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Qyuns Therapeutics Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange  , on May 27, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260527:nNDL1qwklt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163156924","title":"Qyuns Therapeutics secures NMPA approval for biosimilar QX001S (Ustekinumab) in Crohn’s disease, in partnership with Zhongmei Huadong","url":"https://stock-news.laohu8.com/highlight/detail?id=1163156924","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1163156924?lang=en_us&edition=fundamental","pubTime":"2026-05-21 21:03","pubTimestamp":1779368605,"startTime":"0","endTime":"0","summary":"Hong Kong-listed Qyuns Therapeutics Co., Ltd. (Qyuns Therapeutics) announced that Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. (Zhongmei Huadong) has received both a Drug Registration...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193332535","title":"QYUNS-B (02509) Gains Approval for Marketing Authorization and Supplemental Application of QX001S (Ustekinumab Injection) for Crohn's Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=1193332535","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193332535?lang=en_us&edition=fundamental","pubTime":"2026-05-21 20:48","pubTimestamp":1779367695,"startTime":"0","endTime":"0","summary":"QYUNS-B (02509) announced that Sino-American East China recently received the \"Drug Registration Certificate\" and \"Drug Supplemental Application Approval Notice\" issued by the National Medical...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","IPOS","02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637639336","title":"Qyuns Therapeutics - Zhongmei Huadong Receives Approvals for QX001s (Ustekinumab Injection) for Crohn's Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2637639336","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637639336?lang=en_us&edition=fundamental","pubTime":"2026-05-21 20:43","pubTimestamp":1779367433,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nFWN41Y0ST:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131632209","title":"QYUNS-B (02509) Rises Over 3% Following Windward Bio's Completion of $165 Million Crossover Financing to Advance WIN027 Clinical Study","url":"https://stock-news.laohu8.com/highlight/detail?id=1131632209","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131632209?lang=en_us&edition=fundamental","pubTime":"2026-05-11 11:28","pubTimestamp":1778470108,"startTime":"0","endTime":"0","summary":"QYUNS-B (02509) saw its stock price increase by more than 3%. As of the latest update, the share price rose by 3.47% to HK$17.28, with a trading volume of HK$4.2084 million. On May 8, according to an...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02509","BK4585","VXUS","BK1161","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136994307","title":"Qyuns Therapeutics Rolls Out 10-Year Share Incentive Plan; Mandate Capped at 10% of Issued H Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1136994307","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136994307?lang=en_us&edition=fundamental","pubTime":"2026-05-08 20:44","pubTimestamp":1778244253,"startTime":"0","endTime":"0","summary":"Qyuns Therapeutics Co., Ltd. (stock short name: QYUNS-B) released details of its 2026 Share Incentive Scheme, slated for shareholder approval at the 29 May 2026 AGM. Key Terms   • Scheme period: 10...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156173446","title":"Qyuns Therapeutics to Vote on Profit Distribution, KPMG Re-appointment and New 2026 Share Incentive Scheme at 29 May 2026 AGM","url":"https://stock-news.laohu8.com/highlight/detail?id=1156173446","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1156173446?lang=en_us&edition=fundamental","pubTime":"2026-05-08 20:44","pubTimestamp":1778244246,"startTime":"0","endTime":"0","summary":"Qyuns Therapeutics Co., Ltd. will convene its 2026 annual general meeting at 10:00 a.m. on 29 May 2026 in Taizhou, Jiangsu. Shareholders will decide on 13 resolutions covering operational reports,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174436764","title":"Qyuns Therapeutics Tables Key AGM Proposals: No 2025 Dividend, HK$111.70 Million Proceeds Reallocated, Launches 10-Year Share Incentive Scheme","url":"https://stock-news.laohu8.com/highlight/detail?id=1174436764","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174436764?lang=en_us&edition=fundamental","pubTime":"2026-05-08 20:24","pubTimestamp":1778243062,"startTime":"0","endTime":"0","summary":"Qyuns Therapeutics will hold its 2025 annual general meeting on 29 May 2026 in Taizhou, Jiangsu.  The circular released on 8 May 2026 sets out eleven principal resolutions.  Key points are: • No 2025...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633957456","title":"Qyuns Therapeutics announces annual general meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2633957456","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633957456?lang=en_us&edition=fundamental","pubTime":"2026-05-08 20:23","pubTimestamp":1778243015,"startTime":"0","endTime":"0","summary":"Qyuns Therapeutics will hold its annual general meeting in Taizhou City, Jiangsu Province on May 29, 2026.Shareholders will vote on 2025 reporting items, including board report, supervisors report, annual report with audited consolidated financial statements, profit distribution plan, director and supervisor remuneration plan, auditor appointment, and a proposed change in use of global offering proceeds.Special resolutions include proposed general mandates to issue shares and to repurchase H shares.Other items include dissolving supervisory committee with related governance document amendments, and adopting 2026 share incentive scheme with related mandate limits.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Qyuns Therapeutics Co. Ltd","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nNDL19G92p:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02509","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631511466","title":"BRIEF-Qyuns Therapeutics To Subscribe PDB Wealth Product With RMB100 Million Principal","url":"https://stock-news.laohu8.com/highlight/detail?id=2631511466","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631511466?lang=en_us&edition=fundamental","pubTime":"2026-04-29 20:37","pubTimestamp":1777466274,"startTime":"0","endTime":"0","summary":"BRIEF-Qyuns Therapeutics To Subscribe PDB Wealth Product With RMB100 Million PrincipalApril 29 (Reuters) - Qyuns Therapeutics Co Ltd 2509.HK:TO SUBSCRIBE PDB WEALTH PRODUCT WITH RMB100 MILLION PRINCIPAL MATURING OCT 29, 2026Further company coverage: 2509.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260429:nFWN41C0TJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02509","BK1161"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":4,"totalSize":100,"code":"91000000","status":"200"}]}}